...
首页> 外文期刊>COPD: Journal of Chronic Obstructive Pulmonary Disease >Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population.
【24h】

Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population.

机译:管理的护理人群中的慢性阻塞性肺疾病患者的抑郁/焦虑症的临床和经济负担。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Anxiety and depression are common co-morbidities that can complicate the course of chronic obstructive pulmonary disease (COPD). The purpose of this study was to evaluate their impact on healthcare utilization and costs in a managed care COPD population. METHODS: Administrative claims data were used to conduct a retrospective cohort study of COPD patients >/= 40 years of age, including those with co-morbid COPD-Depression (including anxiety). COPD-Depression patients were matched to COPD patients without depression (COPD-Only cohort) using propensity scores. Conditional logistic regression models assessed the 1-year risk of COPD exacerbations (i.e., emergency room [ER] visit/inpatient hospitalization) between cohorts. Differences in annual all-cause and COPD-related utilization/costs, along with 2-year costs, were also compared between the cohorts. RESULTS: There were 3,761 patients per cohort. Patients in the COPD-Depression cohort were 77% more likely to have a COPD-related hospitalization (odds ratio [OR] = 1.77, P < 0.001), 48% more likely to have an ER visit (OR = 1.48, P < 0.001), and 60% more likely to have hospitalization/ER visit (OR = 1.60, P < 0.001) compared to the COPD-Only cohort. Average annual all-cause medical cost per patient was Dollars 23,759 for COPD-Depression vs Dollars 17,765 for COPD-Only (P < 0.001) and total (medical plus pharmacy) cost was Dollars 28,961 vs Dollars 22,512 (P < 0.001), respectively; corresponding average annual COPD-related medical cost was Dollars 2,040 vs Dollars 1,392 (P < 0.001) and total cost was Dollars 3,185 vs Dollars 2,680 (P < 0.001). Similar trends were observed over the 2-year period. CONCLUSIONS: In the COPD population, patients with depression/anxiety have significantly higher risk of COPD exacerbations and annual all-cause and COPD-related costs than patients without these co-morbidities. These findings may have therapeutic implications and seem worthy of further exploration.
机译:背景:焦虑和抑郁是常见的合并症,可以使慢性阻塞性肺疾病(COPD)的病情复杂化。这项研究的目的是评估其对管理型COPD人群中医疗保健利用率和成本的影响。方法:使用行政索赔数据对≥40岁的COPD患者(包括合并患有COPD抑郁症(包括焦虑症)的患者)进行回顾性队列研究。使用倾向评分将COPD抑郁症患者与无抑郁症的COPD患者(仅COPD队列)进行匹配。条件Logistic回归模型评估了队列之间COPD恶化的1年风险(即急诊室[ER]访视/住院患者住院)。队列之间的年度全因和COPD相关利用率/成本以及2年成本的差异也进行了比较。结果:每个队列有3,761名患者。患有COPD抑郁的人群中与COPD相关的住院治疗的可能性高77%(几率[OR] = 1.77,P <0.001),有ER访视的可能性高48%(OR = 1.48,P <0.001) ),与仅COPD队列相比,住院/急诊就诊的可能性高60%(OR = 1.60,P <0.001)。每位患者的平均每年全因医疗费用分别为:COPD-抑郁症为23,759美元,而COPD-Only为17,765美元(P <0.001),总(医疗加药房)费用分别为28,961美元和22,512美元(P <0.001);相应的与COPD相关的年度平均医疗费用为2,040美元与1,392美元(P <0.001),总费用为3,185美元与2,680美元(P <0.001)。在两年期间观察到类似趋势。结论:在COPD人群中,抑郁/焦虑症患者的COPD恶化风险以及每年的全因和COPD相关费用要比无这些合并症的患者高得多。这些发现可能具有治疗意义,似乎值得进一步探索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号